To the best of my knowledge, this is the first study to evaluate QOL after Pola-RTX-mini-CHP, VR-mini-CHP, BV-mini-CHP, or MOG-mini-CHOP for patients with lymphoma aged ≥80 years. This evidence concerns the gene MOG and lymphoma.